Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...
WuXi Biologics, a wholly owned subsidiary of WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform...
SHANGHAI; CAMBRIDGE, Mass.; and MOUNTAIN VIEW, Calif., April 22, 2015 /PRNewswire/ – WuXi PharmaTech (Cayman) Inc. (NYSE: WX), whose leading...
WuXiPRA, a leading clinical services company with operations in the greater China region, today announced appointments of two key executives. Liedong ...
WuXi PharmaTech (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and...
WuXi PharmaTech stated today that a recent news report regarding purported FDA communication with a company named Novacyl Wuxi Pharmaceutical does...
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China...
WuXiPharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in ...
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development services company serving the pharmaceutical, biotechnology, and medical...
WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China...
More than 400 life science innovators recently tuned in to a global webinar hosted by WuXi AppTec to gain insights into the advancement of programs...
Targos GmbH, a leader in clinical biomarker services, and WuXi PharmaTech (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device R&D...
WuXi PharmaTech (NYSE: WX) today announced that its toxicology facility in Suzhou had received a statement of Good Laboratory Practice (GLP) from the ...
WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2013, with the...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.